image
mobile_image
headline
Why choose the maternal RSV vaccination?
content
The CDC recommends ABRYSVO® if you are 32 through 36 weeks pregnant during September through January (in most of the United States) to prevent RSV in infants from birth through 6 months of age. In areas where RSV does not follow typical seasonal patterns, the recommended months for maternal vaccination may differ. Talk to your OB to see if you are eligible.
disclaimer
RSV=respiratory syncytial virus.
Actor portrayal
Actor portrayal
placeholder_icon
placeholder_title
On this page you’ll discover:
placeholder_body
headline
How does maternal immunization with ABRYSVO protect your baby?
content
- Maternal immunization with ABRYSVO involves vaccinating a pregnant woman so protective antibodies can be passed to the baby through the placenta before birth.
- During pregnancy, your body naturally passes on antibodies that help protect your baby against bacteria and viruses, like RSV, in the first few months of life, before they’re old enough to develop their own protection. Pfizer’s ABRYSVO helps your body create RSV antibodies that are passed to your unborn baby to help protect them from birth through 6 months.
- Eligible pregnant women can choose to receive Pfizer’s RSV vaccine ABRYSVO between 32 through 36 weeks of pregnancy.
ABRYSVO should not be given to anyone with a history of severe allergic reaction (e.g., anaphylaxis) to any of its components. Vaccination with ABRYSVO may not protect all people. Click here for Important Safety Information.
image
mobile_image
headline
ABRYSVO is the only RSV vaccine that enables a pregnant woman to pass RSV protection to their baby
content
Helping to protect their baby from birth through their first vulnerable 6 months of life.
buttons
image
mobile_image
headline
Pfizer’s vaccine ABRYSVO helps protect your baby against RSV
content
ABRYSVO was studied in a clinical trial including over 7,000 pregnant women and their babies, where 3,695 pregnant women received ABRYSVO and 3,697 received a placebo. The study showed ABRYSVO reduced the risk of severe RSV by ~69% compared with placebo in infants measured at 6 months after birth.
Talk to your OB about how to protect your baby from RSV and whether ABRYSVO is right for you. To avoid the potential risk of preterm birth, ABRYSVO should only be given between 32 through 36 weeks of pregnancy.
Learn more about RSV and ABRYSVO with our Frequently Asked Questions.
Talk to your OB about how to protect your baby from RSV and whether ABRYSVO is right for you. To avoid the potential risk of preterm birth, ABRYSVO should only be given between 32 through 36 weeks of pregnancy.
Learn more about RSV and ABRYSVO with our Frequently Asked Questions.
buttons
headline
Most common side effects of Pfizer’s ABRYSVO
content
These are not all of the possible side effects. For a full list, please see the full Prescribing Information.
icon
content
Pregnant women who received Pfizer’s ABRYSVO most commonly reported pain at the injection site, headache, muscle pain, and nausea.
icon
content
Low birth weight was observed in 5.1% of infants in the ABRYSVO group vs. 4.4% in the placebo group.
icon
content
Jaundice, also known as temporary yellowing of the eyes and skin, was seen in 7.2% of infants in the ABRYSVO group and 6.7% in the placebo group.
card_identifier
heading
Get to know more about RSV in babies
body
Learn about helping to protect your baby through maternal vaccination.
card_identifier
heading
Find ABRYSVO near you
body
Talk to your OB to see if ABRYSVO is right for you and find a vaccine near you.
cta